These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A quantitative analysis of saccades and smooth pursuit during visual pursuit tracking. A comparison of schizophrenics with normals and substance abusing controls. Radant AD; Hommer DW Schizophr Res; 1992 Mar; 6(3):225-35. PubMed ID: 1349241 [TBL] [Abstract][Full Text] [Related]
7. Quantitative effects of typical and atypical neuroleptics on smooth pursuit eye tracking in schizophrenia. Litman RE; Hommer DW; Radant A; Clem T; Pickar D Schizophr Res; 1994 May; 12(2):107-20. PubMed ID: 8043521 [TBL] [Abstract][Full Text] [Related]
8. [Eye tracking disorders in schizophrenic patients and their parents]. Boudet C; Denise P; Bocca ML; Chabot B; Abadie P; Brazo P; Benali K; Dollfus S Encephale; 2001; 27(6):551-8. PubMed ID: 11865562 [TBL] [Abstract][Full Text] [Related]
9. Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia. Lencer R; Sprenger A; Harris MS; Reilly JL; Keshavan MS; Sweeney JA Arch Gen Psychiatry; 2008 Oct; 65(10):1146-54. PubMed ID: 18838631 [TBL] [Abstract][Full Text] [Related]
10. Smooth pursuit eye movements in schizophrenia: influences of neuroleptic treatment and the question of specificity. Küfferle B; Friedmann A; Topitz A; Földes P; Anderer P; Kutzer M; Steinberger K Psychopathology; 1990; 23(2):106-14. PubMed ID: 1979684 [TBL] [Abstract][Full Text] [Related]
11. Saccadic abnormalities in psychotic patients. II. The role of neuroleptic treatment. Crawford TJ; Haeger B; Kennard C; Reveley MA; Henderson L Psychol Med; 1995 May; 25(3):473-83. PubMed ID: 7480428 [TBL] [Abstract][Full Text] [Related]
12. The effect of change in clinical state on eye movement dysfunction in schizophrenia. Kallimani D; Theleritis C; Evdokimidis I; Stefanis NC; Chatzimanolis I; Smyrnis N Eur Psychiatry; 2009 Jan; 24(1):17-26. PubMed ID: 18922684 [TBL] [Abstract][Full Text] [Related]
13. Eye movement research with schizophrenic patients and normal controls using corneal reflection-pupil center measurement. Gaebel W; Ulrich G; Frick K Eur Arch Psychiatry Neurol Sci; 1986; 235(4):243-54. PubMed ID: 2870925 [TBL] [Abstract][Full Text] [Related]
14. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics. Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028 [TBL] [Abstract][Full Text] [Related]
15. Smooth pursuit eye movements in the evaluation of famotidine adjunctive therapy of schizophrenia: a preliminary report. Rosenberg PB; Rosse RB; Johri SK; Kendrick K; Fay-McCarthy M; Collins JP; Tsui LC; Wyatt RJ; Deutsch SI Clin Neuropharmacol; 1996 Jun; 19(3):276-81. PubMed ID: 8726548 [TBL] [Abstract][Full Text] [Related]
16. Basic parameters of saccadic eye movements--differences between unmedicated schizophrenia and affective disorder patients. Mahlberg R; Steinacher B; Mackert A; Flechtner KM Eur Arch Psychiatry Clin Neurosci; 2001 Oct; 251(5):205-10. PubMed ID: 11829206 [TBL] [Abstract][Full Text] [Related]
17. Effects of nicotine on leading saccades during smooth pursuit eye movements in smokers and nonsmokers with schizophrenia. Avila MT; Sherr JD; Hong E; Myers CS; Thaker GK Neuropsychopharmacology; 2003 Dec; 28(12):2184-91. PubMed ID: 12968127 [TBL] [Abstract][Full Text] [Related]
18. SPEM impairment in drug-naive schizophrenic patients: evidence for a trait marker. Campion D; Thibaut F; Denise P; Courtin P; Pottier M; Levillain D Biol Psychiatry; 1992 Nov; 32(10):891-902. PubMed ID: 1361365 [TBL] [Abstract][Full Text] [Related]